NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

The data was not presented with truly patient level data as the clinicians were unable to access it. It would mean accessing the per person trial data from the Novocure trial used in the ECA, and there is likely no way that Novocure is going to hand that over to Northwest... ever. So they used other acceptable means to create as close to patient level data as possible, and that is the information I cited from the JAMA supplement provided in the P3 DCVax-L paper. I did not intend to confuse anyone, but rather buttress your case that while the data was not really patient level, it was more than made up for by all the various acceptable methods they used to present it.